Rockwell Medical (RMTI) Gains from Investment Securities (2017 - 2020)
Rockwell Medical's (RMTI) quarterly Gains from Investment Securities came in at $837000.0 in Q2 2020, up 76.63% on a QoQ basis from $473871.0 in Q2 2017.
Rockwell Medical (RMTI) Gains from Investment Securities (2017 - 2020) Analysis & Trends
Rockwell Medical (RMTI) has 2 years of Gains from Investment Securities data on file, last reported at $837000.0 in Q2 2020.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $837000.0 in Q2 2020, while the trailing twelve-month figure through Jun 2021 was $837000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $77000.0, up 28.33% from the prior year.
- Gains from Investment Securities advanced to $837000.0 in Q2 2020, from $473871.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $837000.0 in Q2 2020 to a low of $473871.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Rockwell Medical | 30.62 Mn | 5.82 Mn | 3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 837,000.00 |
| Jun 30, 2020 | 837,000.00 |
| Jun 30, 2017 | 473,871.00 |
| Jun 30, 2017 | 473,871.00 |